Medication can be considered for prediabetes, peak groups say

Although intensive lifestyle interventions are the mainstay, some patients might benefit from adding pharmaceutical agents, a position statement reads

GPs can consider metformin or other glucose-lowering drugs to prevent progression to type 2 diabetes in patients with prediabetes, a new Australian position statement says.

However, pharmacotherapy should only be an option in younger adults who fail to respond to lifestyle interventions alone, according to peak diabetes groups, including the Australian Diabetes Society (ADS) and the Australian Diabetes Educators Association.

The updated position statement, published in May, provides guidance for the screening and management of prediabetes in the primary care